Assignee
TRANSCRIPTX INC
US·3 granted patents·3 pending applications·11 citations·filing 2018–2023
Top patents by PatentIndex Score
6 records- 0194US11786610B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Oct 17, 2023·4 cites·20 claims
- 0294US11510997B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Nov 29, 2022·5 cites·26 claims
- 0390US11642421B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2020·Granted May 9, 2023·2 cites·65 claims
- 0481US2024285798A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2023·Application pending·0 cites
- 0570US2019117796A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
- 0670US2019111074A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →